bone mineral density cost-effective; fracture; osteoarthritis; osteoporosis; quality of life
Abstract :
[en] The Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), which was held in Porto between March 28 and March 30, 2007, was the largest meeting in Europe in the field of osteoporosis and osteoarthritis. The meeting was attended by similar to 4000 scientists and health professionals seeking information on the epidemiology, pathogenesis, prevention and treatment of osteoporosis and osteoarthritis. Specifically addressing these topics, > 500 abstracts were submitted. This paper highlights and summarises the important findings of ECCEO 2007.
Disciplines :
General & internal medicine
Author, co-author :
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Language :
English
Title :
Highlights from the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
SEEMAN, E., Why do bones break? A reappraisal of mechanisms of bone fragility (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S1-S2
HAENTJENS, P., BOONEN, S., Excess mortality after hip fracture among postmenopausal women and ageing men: Evidence from data searches and life-table analyses for gender-related differences in absolute risk of death after hip fracture (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S5-S6
STRÖM, O., BORGSTRÖM, F., ZETHRAEUS, N., JOHNELL, O., JöNSSON, B., Long term quality of life related to osteoporotic fractures. 13-18 months after fracture (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S6
SZULC, P., DELMAS, P.D., Prevalent falls predict incident non-vertebral fractures in elderly men - prospective minos study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S5
HADJI, P., NICKELSEN, T., MARIN, F., Bone mineral density response to 2 years of continuous treatment with teriparatide: Final results from the eurofors study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S7
DELMAS, P.D., SILVERMAN, S.L., WATTS, N.B., LANGE, J.L., LINDSAY, R., Risedronate and alendronate for the reduction of nonvertebral fractures, a retrospective cohort study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S7-S8
FELSENBERG, D., MILLER, P.D., LEWIECKI, E.M., LIBANATI, C., LIU, Y., BECK, T.J., Hip structural analysis of the proximal femur in postmenopausal women with low bone mass treated with denosumab (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S9
LYNCH, N.O., EARNSHAW, S.R., GRAHAM, C.N., MIDDELHOVEN, H., Cost-effectivenss of ibandronate injection IV in the treatment of uk women with postmenopausal osteoporosis who are intolerant to oral bispbosphonates (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S11-S12
STOCH, S.A., MILLER, D.L., VAN DYCK, K., Effect of cathepsin k inhibition on bone resorption markers in healthy postmenopausal women (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S8-S9
LIPS, P., PFEIFER, M., WALLISER, J., Treatment effects of vitamin d3 8400 iu once weekly on body sway of elderly subjects with vitamin D insufficiency (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S11
BOONEN, S., WARDLAW, D., BASTIAN, L., LIPS, R., VAN MEIRHAEGHE, J., CUMMINGS, S., International multicenter randomized comparison of balloon kyphoplasty and non-surgical management in patients with acute vertebral body compression fractures (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S10-S11
REGINSTER, J.-Y., BRIXEN, K., CORMIER, C., CANNATA, J., Strontium ranelate demonstrates vertebral and non-vertebral anti fracture efficacy including hip fractures over 5 years in post menopausal osteoporotic women (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S21
BLACK, D.M., DELMAS, P.D., EASTELL, R., Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: The horizon pivotal fracture trial (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S21
CHAPURLAT, R.D., ARLOT, M., BURT-PICHAT, B., Effect of long-term bisphosphonates on bone turnover and microdamage in osteoporotic women: A bone biopsy study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S10
JUNG, T.I., VON DER GABLENTZ, J., FELSENBERG, D., Osteonecrosis of the jaw under bisphosphonate therapy - a german register for patents with osteonecrosis of the jaw (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S8
DERE, W., Are anti-osteoporotic agents the solution for treating osteoarthritis? (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S2-S3
ZHAI, G., HART, D.J., KATO, B.S., SHARMA, L., MACGREGOR, A., SPECTOR, T.D., Genetic contribution to knee radiographic osteoarthritis and knee alignment: A longitudinal twin study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S12
MARTEL-PELLETIER, J., RAYNAULD, J.P., BERTHIAUME, M.J., The loss of cartilage volume/thickness on the weight bearing areas in knee osteoarthritic patients, assessed by quantitative MRI, is correlated with severity of symptoms and worsening of pain over time (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S12-S13
BEATTIE, K.A., DURYEA, J., PUI, M., The contribution of medial femoral and tibial cartilage thickness to minimum joint space width in osteoarthritic knees (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S13
BEATTIE, K.A., DURYEA, J., PUI, M., Minimum joint space width values in healthy individuals and patients with knee OA (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S13-S14
HUELS, J., OMAR, M., DUBOIS, R.W., DOAN, Q.V., Lumiracoxib is cost-effective compared with celecoxib and NSAID plus proton pump inhibitor combinations for the management of osteoarthritis among patients with a prior gastrointestinal event in the United Kingdom (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S14
KAHAN, A., VIGNON, E., UEBELHART, D., REGINSTER, J.-Y., A randomized controlled trial with chondroitin sulfate involving over 600 patients: STOPP (study on osteoarthritis progressinn prevention) (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S14-S15
HERRERO-BEAUMONT, G., BRANCO, J., FOR, T.G., INVESTIGATORS. Glucosamine sulfate improves quality of life of knee osteoarthritis patients in the glucosamine unum in die efficacy (GUIDE) trial (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S16
BRUYÈRE, O., DELFERRIERE, D., ROUX, C., FECHTENBAUM, J., KOLTA, S., REGINSTER, J.-Y., Strontium ranelate prevents spine osteoarthritis progression in patients with prevalent spinal osteoarthritis (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S16-S17
PELLETIER, J.-P., RAYNAULD, J.-P., BIAS, P., Licofelone, a 5-lipoxygenase and cyclooxygenase inhibitor, reduces the progression of knee osteoarthritis (OA): A double blind, multicenter two-year study using quantitative MRI (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S18
COHEN, S.B., VALEN, P., RITCHLIN, C., Inhibition of rank1 with denosumab decreases progression of bone erosions in patients with rheumatoid arthritis: MRI results at 6 months (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S15-S16
LANE, N., IANNINI, M., ATKINS, C., Inhibition of RANKL with denosumab reduces markers of bone and cartilage turnover in patients with rheumatoid arthritis (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S17-S18
QUESADA GÓMEZ JM, C.X., RAMÍREZ, E., Adherence to therapeutic recommendation for calcium + vitamin D supplementation in the pharmacologic treatment of postmenopausal osteoporosis in spain: The combicad study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S19
PIERCY, J., BADAMGARAV, E., TIMPERS, E., TOMPKINS, R., Impact of incomplete patient compliance with medication instructions for bisphosphonate therapy on healthcare utilization and quality of life (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S19
RABENDA, V., REGINSTER, J.-Y., Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S19-520
DANESE, M., BADAMGARAV, E., BAUER, D., Poor patient adherence to osteoporosis treatment is associated with an increased rate and cost of hip fracture (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S20
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
